{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:10:20Z","timestamp":1779318620139,"version":"3.51.4"},"reference-count":46,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2017.7274","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T10:27:25Z","timestamp":1509013645000},"source":"Crossref","is-referenced-by-count":2,"title":["Cancer\u2011testis antigens are predominantly expressed in uterine leiomyosarcoma compared with non\u2011uterine leiomyosarcoma"],"prefix":"10.3892","author":[{"given":"Kunio","family":"Iura","sequence":"first","affiliation":[{"name":"Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka 812\u20118581, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Kohashi","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka 812\u20118581, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuko","family":"Yasutake","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka 812\u20118581, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeaki","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka 812\u20118581, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Maekawa","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka 812\u20118581, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Bekki","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka 812\u20118581, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka 812\u20118581, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka 812\u20118581, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetaka","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka 812\u20118581, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Ohishi","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka 812\u20118581, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka 812\u20118581, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihide","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka 812\u20118581, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinao","family":"Oda","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka 812\u20118581, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,10,26]]},"reference":[{"key":"key20200714082213_b1-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/bjc.1995.357","article-title":"Adjuvant chemotherapy for soft-tissue sarcoma: Review and meta-analysis of the published results of randomised clinical trials","volume":"72","author":"Tierney","year":"1995","journal-title":"Br J Cancer"},{"key":"key20200714082213_b2-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1002\/ijc.22239","article-title":"Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978\u20132001: An analysis of 26,758 cases","volume":"119","author":"Toro","year":"2006","journal-title":"Int J Cancer"},{"key":"key20200714082213_b3-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","article-title":"Uterine sarcomas: A review","volume":"116","author":"D'Angelo","year":"2010","journal-title":"Gynecol Oncol"},{"key":"key20200714082213_b4-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1200\/JCO.1999.17.1.150","article-title":"Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: An analysis of 2,185 patients treated with anthracycline-containing first-line regimens-a European organization for research and treatment of cancer soft tissue and bone S","volume":"17","author":"Van Glabbeke","year":"1999","journal-title":"J Clin Oncol"},{"key":"key20200714082213_b5-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S1470-2045(03)00982-3","article-title":"Cancer\/testis tumour-associated antigens: Immunohistochemical detection with monoclonal antibodies","volume":"4","author":"Juretic","year":"2003","journal-title":"Lancet Oncol"},{"key":"key20200714082213_b6-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1074-7613(00)80426-4","article-title":"Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor","volume":"6","author":"Ikeda","year":"1997","journal-title":"Immunity"},{"key":"key20200714082213_b7-ol-0-0-7274","first-page":"7","article-title":"The frequent expression of cancer\/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma","volume":"4","author":"Ayyoub","year":"2004","journal-title":"Cancer Immun"},{"key":"key20200714082213_b8-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1016\/j.vaccine.2014.09.002","article-title":"High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine","volume":"32","author":"Saito","year":"2014","journal-title":"Vaccine"},{"key":"key20200714082213_b9-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00262-015-1731-3","article-title":"A phase I trial combining decitabine\/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma","volume":"64","author":"Krishnadas","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"key20200714082213_b10-ol-0-0-7274","first-page":"33","article-title":"WHO Classification of tumor of Tissue and Bone","author":"Christopher","year":"2013","journal-title":"Int. Agency Res. Cancer"},{"key":"key20200714082213_b11-ol-0-0-7274","first-page":"139","article-title":"WHO classification of tumours Female Reproductive Organs","author":"Kurman","year":"2014","journal-title":"Int. Agency Res. Cancer"},{"key":"key20200714082213_b12-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/cjp2.16","article-title":"Cancer-testis antigens PRAME and NY-ESO-1 correlate with tumour grade and poor prognosis in myxoid liposarcoma","volume":"1","author":"Iura","year":"2015","journal-title":"J Pathol Clin Res"},{"key":"key20200714082213_b13-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/modpathol.2013.244","article-title":"Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2 and CTAG2 in myxoid and round cell liposarcoma","volume":"9","author":"Hemminger","year":"2014","journal-title":"Mod Pathol"},{"key":"key20200714082213_b14-ol-0-0-7274","first-page":"1","article-title":"Cancer-testis (CT) antigen expression in medulloblastoma","volume":"8","author":"Oba-Shinjo","year":"2008","journal-title":"Cancer Immun"},{"key":"key20200714082213_b15-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/hed.10223","article-title":"Identification of NY-ESO-1, MAGE-1 and MAGE-3 in head and neck squamous cell carcinoma","volume":"25","author":"Kienstra","year":"2003","journal-title":"Head Neck"},{"key":"key20200714082213_b16-ol-0-0-7274","first-page":"974","article-title":"MAGE-1 and MAGE-3 tumor rejection antigens in human germ cell tumors","volume":"12","author":"Cheville","year":"1999","journal-title":"Mod Pathol"},{"key":"key20200714082213_b17-ol-0-0-7274","first-page":"2281","article-title":"Expression of MAGE-A cancer\/testis antigens in esophageal squamous cell carcinomas","volume":"26","author":"Haier","year":"2006","journal-title":"Anticancer Res"},{"key":"key20200714082213_b18-ol-0-0-7274","first-page":"975","article-title":"The heterogeneous expression of MAGE-3 protein: Difference between primary lesions and metastatic lymph nodes in gastric carcinoma","volume":"6","author":"Sadanaga","year":"1999","journal-title":"Oncol Rep"},{"key":"key20200714082213_b19-ol-0-0-7274","first-page":"5037","article-title":"Expression of the MAGE 3 gene product in squamous cell carcinomas of the head and neck","volume":"19","author":"Lee","year":"1999","journal-title":"Anticancer Res"},{"key":"key20200714082213_b20-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1440-1827.2003.01605.x","article-title":"Expression of MAGE-A3 in intrahepatic cholangiocarcinoma and its precursor lesions","volume":"54","author":"Tsuneyama","year":"2004","journal-title":"Pathol Int"},{"key":"key20200714082213_b21-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/pros.20312","article-title":"Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3\/4 and NY-ESO-1 in cancerous and benign prostatic tissue","volume":"66","author":"Hudolin","year":"2006","journal-title":"Prostate"},{"key":"key20200714082213_b22-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/ijc.10585","article-title":"Cancer-testis antigen expression in uterine malignancies with an emphasis on carcinosarcomas and papillary serous carcinomas","volume":"101","author":"Resnick","year":"2002","journal-title":"Int J Cancer"},{"key":"key20200714082213_b23-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/ijc.10540","article-title":"Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: A tissue microarray study","volume":"100","author":"Kocher","year":"2002","journal-title":"Int J Cancer"},{"key":"key20200714082213_b24-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1159\/000070305","article-title":"Expression of cancer\/testis tumor associated antigens in cervical squamous cell carcinoma","volume":"64","author":"Sarcevic","year":"2003","journal-title":"Oncology"},{"key":"key20200714082213_b25-ol-0-0-7274","first-page":"32","article-title":"Expression and possible prognostic role of MAGE-A4, NY-ESO-1 and HER-2 antigens in women with relapsing invasive ductal breast cancer: Retrospective immunohistochemical study","volume":"47","author":"Bandi\u0107","year":"2006","journal-title":"Croat Med J"},{"key":"key20200714082213_b26-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/hed.21880","article-title":"Expression of cancer-testis antigens MAGE-A4 and MAGE-C1 in oral squamous cell carcinoma","volume":"34","author":"Montoro","year":"2012","journal-title":"Head Neck"},{"key":"key20200714082213_b27-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"e17876","DOI":"10.1371\/journal.pone.0017876","article-title":"Multiple cancer\/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancers","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"key":"key20200714082213_b28-ol-0-0-7274","first-page":"11","article-title":"Expression of the cancer\/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)-correlation with prognostic factors","volume":"7","author":"Velazquez","year":"2007","journal-title":"Cancer Immun"},{"key":"key20200714082213_b29-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1002\/ijc.28752","article-title":"Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer","volume":"135","author":"Laban","year":"2014","journal-title":"Int J Cancer"},{"key":"key20200714082213_b30-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"e67876","DOI":"10.1371\/journal.pone.0067876","article-title":"The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer","volume":"8","author":"John","year":"2013","journal-title":"PLoS One"},{"key":"key20200714082213_b31-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/his.12365","article-title":"The utility of immunostaining for NUT, GAGE7 and NY-ESO-1 in the diagnosis of spermatocytic seminoma","volume":"65","author":"Kao","year":"2014","journal-title":"Histopathology"},{"key":"key20200714082213_b32-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/jjco\/hys236","article-title":"Heterogeneous expression of CT10, CT45 and GAGE7 antigens and their prognostic significance in human breast Carcinoma","volume":"43","author":"Zhou","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"key20200714082213_b33-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3892\/or.2012.1956","article-title":"Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial","volume":"28","author":"Oshita","year":"2012","journal-title":"Oncol Rep"},{"key":"key20200714082213_b34-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1158\/1078-0432.CCR-14-1559","article-title":"Adoptive transfer of MAGE-A4 T-cell receptor gene-transduced lymphocytes in patients with recurrent esophageal cancer","volume":"21","author":"Kageyama","year":"2015","journal-title":"Clin Cancer Res"},{"key":"key20200714082213_b35-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1200\/JCO.2010.32.2537","article-title":"Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1","volume":"29","author":"Robbins","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20200714082213_b36-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/modpathol.2012.31","article-title":"NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: Significance for NY-ESO-1-based targeted therapy and differential diagnosis","volume":"25","author":"Lai","year":"2012","journal-title":"Mod Pathol"},{"key":"key20200714082213_b37-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/modpathol.2014.155","article-title":"NY-ESO-1 (CTAG1B) expression in mesenchymal tumors","volume":"28","author":"Endo","year":"2015","journal-title":"Mod Pathol"},{"key":"key20200714082213_b38-ol-0-0-7274","first-page":"7","article-title":"The frequent expression of cancer\/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma","volume":"4","author":"Ayyoub","year":"2004","journal-title":"Cancer Immun"},{"key":"key20200714082213_b39-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1093\/nar\/gkh735","article-title":"MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription","volume":"32","author":"Laduron","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"key20200714082213_b40-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1158\/0008-5472.CAN-05-3327","article-title":"Melanoma antigen A4 is expressed in non-small cell lung cancers and promotes apoptosis","volume":"66","author":"Peikert","year":"2006","journal-title":"Cancer Res"},{"key":"key20200714082213_b41-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3892\/or.2012.1934","article-title":"MAGEA4 induces growth in normal oral keratinocytes by inhibiting growth arrest and apoptosis","volume":"28","author":"Bhan","year":"2012","journal-title":"Oncol Rep"},{"key":"key20200714082213_b42-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1158\/1078-0432.CCR-07-5279","article-title":"Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer","volume":"14","author":"Woloszynska-Read","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20200714082213_b43-ol-0-0-7274","first-page":"7959","article-title":"Activation of melanoma antigen tumor antigens occurs early in lung cancer carcinogenesis","volume":"61","author":"Jang","year":"2001","journal-title":"Cancer Res"},{"key":"key20200714082213_b44-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.humpath.2011.12.020","article-title":"Oncofetal protein IMP3: A useful diagnostic biomarker for leiomyosarcoma","volume":"43","author":"Cornejo","year":"2012","journal-title":"Hum Pathol"},{"key":"key20200714082213_b45-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0925-4773(99)00160-4","article-title":"Expression of the highly conserved RNA binding protein KOC in embryogenesis","volume":"88","author":"Mueller-Pillasch","year":"1999","journal-title":"Mech Dev"},{"key":"key20200714082213_b46-ol-0-0-7274","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1128\/MCB.19.2.1262","article-title":"A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development","volume":"19","author":"Nielsen","year":"1999","journal-title":"Mol Cell Biol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T07:48:28Z","timestamp":1594712908000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2017.7274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,26]]},"references-count":46,"URL":"https:\/\/doi.org\/10.3892\/ol.2017.7274","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,26]]}}}